Is rechallenge appropriate in patients that developed immune checkpoint inhibitor-associated AKI? Commentary
This is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the PRO: 10.34067/KID.0003962021 and CON: 10.34067/KID.0003902021
Keyword(s):